These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7383089)

  • 1. Malignant thyroid tumors after iodine-131 therapy: a retrospective cohort study.
    Holm LE; Dahlqvist I; Israelsson A; Lundell G
    N Engl J Med; 1980 Jul; 303(4):188-91. PubMed ID: 7383089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risks after diagnostic doses of 131I with special reference to thyroid cancer.
    Holm LE
    Cancer Detect Prev; 1991; 15(1):27-30. PubMed ID: 2044071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. II. Estimation of thyroid gland size, thyroid radiation dose, and predicted versus observed number of malignant thyroid tumors.
    Holm LE; Eklund G; Lundell G
    J Natl Cancer Inst; 1980 Dec; 65(6):1221-4. PubMed ID: 6933269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term comparative cancer mortality after use of radio-iodine in the treatment of hyperthyroidism, a fully reported multicenter study.
    Singer RB
    J Insur Med; 2001; 33(2):138-42. PubMed ID: 11510511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cancer after diagnostic administration of iodine-131.
    Hall P; Mattsson A; Boice JD
    Radiat Res; 1996 Jan; 145(1):86-92. PubMed ID: 8532842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer following iodine-131 therapy for hyperthyroidism.
    Hoffman DA; McConahey WM
    J Natl Cancer Inst; 1983 Jan; 70(1):63-7. PubMed ID: 6571923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
    Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
    J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cancer incidence after radioiodine treatment for hyperthyroidism.
    Metso S; Auvinen A; Huhtala H; Salmi J; Oksala H; Jaatinen P
    Cancer; 2007 May; 109(10):1972-9. PubMed ID: 17393376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine treated hyperthyroidism and thyroid carcinoma.
    Appell R; Tsangaris N; Spiegel J
    Am Surg; 1978 Aug; 44(8):537-40. PubMed ID: 707910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. I. Retrospective cohort study.
    Holm LE; Lundell G; Walinder G
    J Natl Cancer Inst; 1980 May; 64(5):1055-9. PubMed ID: 6929011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyroid cancer risk from iodine-131-treatment? (author's transl)].
    Creutzig H; Hundeshagen H
    Med Klin; 1977 May; 72(19):855-7. PubMed ID: 865388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
    Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
    Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid cancer after exposure to radioactive 131I.
    Holm LE
    Acta Oncol; 2006; 45(8):1037-40. PubMed ID: 17118835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer after irradiation.
    Chang-Chien Y; Liaw KY; Wang DJ; Chen FW
    Int Surg; 1977 Feb; 62(2):112-4. PubMed ID: 844967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of solitary autonomous thyroid nodules treated with 131I.
    Goldstein R; Hart IR
    N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
    Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules.
    Sharma R; Bhatnagar A; Mondal A; Kashyap R; Khanna CM
    J Assoc Physicians India; 1995 Mar; 43(3):167-9, 172. PubMed ID: 11256900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.